Leukemia, Myelodysplasia, Transplantation
Conference Coverage
Allo-HSCT plus monoclonal antibody treatment can improve survival in patients with r/r B-ALL
Conference Coverage
Omidubicel improves on umbilical cord blood transplants
From the Journals
Updated recommendations released on COVID-19 and pediatric ALL
From the Journals
Don’t delay: Cancer patients need both doses of COVID vaccine
For patients with cancer, immune response to the first dose of the Pfizer COVID-19 vaccine is reduced, and there is a need for a booster dose at...
From the Journals
New inhibitor shows promise in previously failed B-cell malignancies
Pirtobrutinib (formerly known as LOXO-305) is an oral-dose, highly selective, reversible inhibitor.
Clinical Insights
mCODE: Improving data sharing to enhance cancer care
Conference Coverage
Maribavir seen as superior to other antivirals for CMV clearance post transplant
News
FDA places clinical hold on sickle cell gene therapy
Conference Coverage
Using engineered T cells reduced acute, chronic GVHD
Conference Coverage
Transplant-related mortality higher with CD34 selection
Conference Coverage
Steroid complications in GVHD common, boost costs of care